TY - JOUR
T1 - Longitudinal study of falls among HIV-infected and uninfected women
T2 - The role of cognition
AU - Sharma, Anjali
AU - Hoover, Donald R.
AU - Shi, Qiuhu
AU - Holman, Susan
AU - Plankey, Michael W.
AU - Tien, Phyllis C.
AU - Weber, Kathleen M.
AU - Floris-Moore, Michelle
AU - Bolivar, Hector H.
AU - Vance, David E.
AU - Golub, Elizabeth T.
AU - McDonnell Holstad, Marcia
AU - Yin, Michael T.
N1 - Funding Information:
Data in this manuscript were collected by the Women’s Interagency HIV Study (WIHS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). A list of the WIHS principal investigators can be found in Additional file 1. The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. This research was also supported by National Institutes of Health K23AR06199301 (AS).
Publisher Copyright:
© 2018 International Medical Press.
PY - 2018
Y1 - 2018
N2 - Background: Although fracture rates are higher in HIV+ HIV- women, including ≥2 falls in 25% HIV+ and 24% HIV-than HIV- women, whether HIV infection increases risk (overall P=0.30). Cognitive complaints were associated of falls is unclear. We determined the longitudinal occur-with falls among HIV+ (odds ratio [OR] 2.38; 95% CI 1.83, rence and risk factors for falls in the Women’s Intera-3.09) and HIV- women (OR 3.43; 95% CI 2.37, 4.97); in gency HIV Study (WIHS), and explored associations with adjusted models, cognitive complaints remained significant cognitive complaints. only in HIV- women (adjusted [aOR] 2.26; 95% CI 1.46, Methods: Recent (prior 6 months) self-reported falls were 3.48). Factors associated with any fall in adjusted analyses collected in 1,816 (1,250 HIV+; 566 HIV-) women over included: depressive symptoms and neuropathy (both HIV+ 24 months. Generalized estimating equation models using and HIV-); age, marijuana use, multiple CNS medications, stepwise selection determined odds of any fall (versus and HCV infection (HIV+ only); and cognitive complaints, none). quality of life, hypertension and obesity (HIV- only). Results: HIV+ women were older than HIV- women Conclusions: Middle-aged HIV+ and HIV- women had (median 49 versus 47 years; P=0.0004), more likely to similar fall rates. Among HIV+ women, factors affecting report neuropathy (20% versus 16%; P=0.023), and had cognition such as age, depressive symptoms, marijuana greater central nervous system (CNS) medication use. use and multiple CNS medications were important predic-At least one fall was reported in 41% HIV+ versus 42% tors of falls, however, cognitive complaints were not.
AB - Background: Although fracture rates are higher in HIV+ HIV- women, including ≥2 falls in 25% HIV+ and 24% HIV-than HIV- women, whether HIV infection increases risk (overall P=0.30). Cognitive complaints were associated of falls is unclear. We determined the longitudinal occur-with falls among HIV+ (odds ratio [OR] 2.38; 95% CI 1.83, rence and risk factors for falls in the Women’s Intera-3.09) and HIV- women (OR 3.43; 95% CI 2.37, 4.97); in gency HIV Study (WIHS), and explored associations with adjusted models, cognitive complaints remained significant cognitive complaints. only in HIV- women (adjusted [aOR] 2.26; 95% CI 1.46, Methods: Recent (prior 6 months) self-reported falls were 3.48). Factors associated with any fall in adjusted analyses collected in 1,816 (1,250 HIV+; 566 HIV-) women over included: depressive symptoms and neuropathy (both HIV+ 24 months. Generalized estimating equation models using and HIV-); age, marijuana use, multiple CNS medications, stepwise selection determined odds of any fall (versus and HCV infection (HIV+ only); and cognitive complaints, none). quality of life, hypertension and obesity (HIV- only). Results: HIV+ women were older than HIV- women Conclusions: Middle-aged HIV+ and HIV- women had (median 49 versus 47 years; P=0.0004), more likely to similar fall rates. Among HIV+ women, factors affecting report neuropathy (20% versus 16%; P=0.023), and had cognition such as age, depressive symptoms, marijuana greater central nervous system (CNS) medication use. use and multiple CNS medications were important predic-At least one fall was reported in 41% HIV+ versus 42% tors of falls, however, cognitive complaints were not.
UR - http://www.scopus.com/inward/record.url?scp=85047180363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047180363&partnerID=8YFLogxK
U2 - 10.3851/IMP3195
DO - 10.3851/IMP3195
M3 - Article
C2 - 28933703
AN - SCOPUS:85047180363
SN - 1359-6535
VL - 23
SP - 179
EP - 190
JO - Antiviral Therapy
JF - Antiviral Therapy
IS - 2
ER -